The Biomedicine Agency, approved by Parliament in August, is intended to screen research applications and allow French health scientists access to the country's stock of excess embryos created through in-vitro fertilization. Under the legislation, the agency is to allow researchers to grow lines of stem cells provided ethical criteria are met and the couples who created the embryos give their consent.

Full Story:

Related Summaries